A.R.T. Advisors’s Tandem Diabetes Care TNDM Stock Holding History

A.R.T. Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-38,513	Closed	-$2.48M	–	1734
2019 Q2	$2.48M	Sell	38,513 -22,300	-37%	-$1.44M	0.14%	188
2019 Q1	$3.86M	Buy	+60,813	New	+$3.19M	0.23%	99
2018 Q3	–	Sell	-82,035	Closed	-$1.81M	–	1711
2018 Q2	$1.81M	Buy	82,035 +43,517	+113%	+$535K	0.07%	399
2018 Q1	$191K	Buy	38,518 +28,499	+284%	+$91.9K	0.01%	1278
2017 Q4	$23K	Buy	+10,019	New	+$31.5K	﹤0.01%	1310
2017 Q3	–	Sell	-9,944	Closed	-$79K	–	1665
2017 Q2	$79K	Buy	+9,944	New	+$91.9K	﹤0.01%	1274
2017 Q1	–	Sell	-5,410	Closed	-$116K	–	1718
2016 Q4	$116K	Buy	+5,410	New	+$208K	0.01%	1131
2016 Q3	–	Sell	-1,434	Closed	-$108K	–	1141
2016 Q2	$108K	Buy	+1,434	New	+$115K	0.01%	1194
2016 Q1	–	Sell	-3,022	Closed	-$356K	–	1645
2015 Q4	$356K	Buy	+3,022	New	+$300K	0.02%	991
2015 Q1	–	Sell	-2,050	Closed	-$260K	–	1688
2014 Q4	$260K	Buy	+2,050	New	+$284K	0.01%	1148

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

A.R.T. Advisors's TNDM Position: Q3 2019 in Review

A.R.T. Advisors sold out of Tandem Diabetes Care (TNDM) in Q3 2019, closing a stake of 38,513 shares — an estimated $2.48M sold.

A.R.T. Advisors first reported a position in TNDM in Q4 2014 and held it in 10 quarters. The position peaked at $3.86M in Q1 2019. 273 funds tracked by Wall St. Rank hold TNDM as of Q3 2019.

A.R.T. Advisors reported no remaining Tandem Diabetes Care position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 38,513 Tandem Diabetes Care shares in Q3 2019, an estimated $2.48M.
A.R.T. Advisors first reported a position in Tandem Diabetes Care in Q4 2014 and held it in 10 quarters.
A.R.T. Advisors's Tandem Diabetes Care position peaked at $3.86M in Q1 2019.
273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.